NEXOBRID Belgian registry: Prospective Assessment of Efficacy of NexoBrid in the treatment of Adult Patients with deep 2nd degree and 3rd degree dermal burns in Belgium.

Study identification

• EU PAS number:
  EUPAS21681
• Study ID:
  21682
• Official title and acronym:
  NEXOBRID Belgian registry: Prospective Assessment of Efficacy of NexoBrid in the treatment of Adult Patients with deep 2nd degree and 3rd degree dermal burns in Belgium.
• DARWIN EU® study:
  No
• Study countries:
  Belgium
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

MediWound Germany

ZNA Campus Stuivenberg Antwerp

Study timelines

Date when funding contract was signed

Actual:15/02/2016

Study start date

Actual:01/03/2016

Date of final study report

Actual:17/10/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MediWound Germany

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable